Table 3.
Human HPV prevalence in women with cervical cytology abnormalities and ISCC.
| Positive | ASC-H (n = 149) |
ASC-US (n = 640) |
HSIL (n = 308) |
LSIL (n = 244) |
ISCC (n = 223) |
|---|---|---|---|---|---|
| HPV | 73 (48.99) | 201 (31.41) | 175 (56.8) | 129 (52.87) | 216 (96.86) |
| HR-HPV | 72 (48.32) | 190 (29.69) | 173 (56.1) | 126 (51.64) | 216 (96.86) |
| LR- HPV | 5 (3.36) | 27 (4.22) | 5 (1.62) | 10 (4.10) | 2 (0.90) |
| Single HPV | 54 (36.24) | 138 (21.56) | 142 (46.10) | 91 (37.30) | 182 (81.61) |
| Multiple HPV | 19 (12.75) | 63 (9.84) | 33 (10.71) | 38 (15.57) | 34 (15.25) |
| Multiple HR-HPV | 16 (10.74) | 59 (9.22) | 33 (10.71) | 35 (14.34) | 34 (15.25) |